Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BiondVax Pharmaceuticals ...

    NASDAQ: BVXV · Real-Time Price · USD
    1.36
    0.01 (0.74%)
    At close: Sep 06, 2023, 9:59 PM

    BiondVax Pharmaceuticals Income Statement

    Financials in ILS. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a 2.75M
    Operating Income
    		 -11.06M -34.83M
    Interest Income
    		 5.26M 3K
    Pretax Income
    		 -5.8M -39.98M
    Net Income
    		 -531K -50.81M
    Selling & General & Admin
    		 5.3M 23.98M
    Research & Development
    		 5.76M 10.34M
    Other Expenses
    		 n/a 509K
    Operating Expenses
    		 11.06M 34.83M
    Interest Expense
    		 n/a 10.83M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 11.06M 34.83M
    Income Tax Expense
    		 -5.26M 10.83M
    Shares Outstanding (Basic)
    		 2.59M 1.41M
    Shares Outstanding (Diluted)
    		 2.59M 1.41M
    EPS (Basic)
    		 -0.2 -36
    EPS (Diluted)
    		 -0.2 -36
    EBITDA
    		 -10.5M -32.44M
    EBIT
    		 -11.06M -29.15M
    Depreciation & Amortization
    		 562K 2.38M

    Add to Watchlist